Mounjaro has sold more than 81,570 units in India, totalling about ₹23.94 crore ($2.76 million) as of May, with the drug ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ...

Pop star Lizzo admitted that she tried Ozempic and other trendy weight loss drugs after denying accusations that she used medications to shed weight. “It’s not easy,” Lizzo confessed during a ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...

A U.S. federal judge has upheld the FDA’s decision to remove semaglutide, the active ingredient in Ozempic and Wegovy, from ...

Enterprise Ireland’s Food Innovation Summit returns to Croke Park, uniting pioneers, startups and global leaders to explore ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

Dr Scales explained that Parkinson's and Alzheimer's share commonality – both are neurodegenerative diseases with overlapping ...

Dietitians are especially excited about one underrated nutrient: prebiotic chicory root fiber. Let’s break down what GLP-1 is ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.